Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11939637 Molecular biomarkers for cancer immunotherapy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 29 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 29 Mar, 2024
Edits made to:
Infobox (+102 properties)
Article (+533 characters)
‌

 US Patent 11939637 Molecular biomarkers for cancer immunotherapy

Article

Patent abstract

In one aspect, provided herein is a method comprising: (a) (i) determining cytolytic activity in a tumor from the subject; and/or (ii) determining genetic alterations associated with cytolytic activity in the tumor; and (b) administering an immunotherapeutic agent to the subject if (i) cytolytic activity is detected in the tumor and/or (ii) a genetic alteration associated with induction of cytolytic activity, tumor resistance to cytolytic activity and/or suppression of cytolytic activity is detected in the tumor.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119396370
Patent Inventor Names
Michael S. Rooney0
Nir Hacohen0
Date of Patent
March 26, 2024
0
Patent Application Number
171799560
Date Filed
February 19, 2021
0
Patent Citations
‌
US Patent 7097842 Modified vaccinia virus ankara for the vaccination of neonates
0
‌
US Patent 7115391 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
0
‌
US Patent 7144575 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7148203 Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
0
‌
US Patent 7160682 Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
0
‌
US Patent 7172893 Virus vectors and methods of making and administering the same
0
‌
US Patent 7175843 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7189536 Modified vaccinia ankara virus variant
0
‌
US Patent 7198784 Retroviral vectors
0
‌
US Patent 7232566 Methods for treating HIV infected subjects
0
‌
US Patent 7255862 ALVAC/FIV constructs
0
‌
US Patent 7259015 Vector system
0
‌
US Patent 7283337 Abutted exchange bias design for sensor stabilization
0
‌
US Patent 7303910 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
0
‌
US Patent 7335364 Modified Vaccinia Ankara virus variant
0
‌
US Patent 7351585 Retroviral vector
0
‌
US Patent 7384644 Modified Vaccinia Ankara virus variant
0
‌
US Patent 7445924 Modified Vaccinia Ankara virus variant and cultivation method
0
‌
US Patent 7459270 Modified Vaccinia Ankara virus variant
0
‌
US Patent 7572631 Activation and expansion of T cells
0
‌
US Patent 7572821 Compounds for the treatment of proliferative disorders
0
‌
US Patent 7608279 Vaccine formulations
0
‌
US Patent 7628980 Modified vaccinia virus ankara for the vaccination of neonates
0
‌
US Patent 7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
0
‌
US Patent 7708949 Method and apparatus for fluid dispersion
0
‌
US Patent 7741465 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 7767449 Methods using modified vaccinia virus
0
‌
US Patent 7892533 Modified vaccinia virus ankara for the vaccination of neonates
0
‌
US Patent 7897156 Modified vaccinia virus ankara for the vaccination of neonates
0
‌
US Patent 7923017 Modified Vaccinia Ankara virus variant
0
‌
US Patent 7939086 Modified Vaccinia Ankara virus variant
0
‌
US Patent 7964395 Modified vaccinia ankara virus variant and cultivation method
0
‌
US Patent 7964396 Modified vaccinia ankara virus variant and cultivation method
0
‌
US Patent 7964398 Modified vaccinia ankara virus variant and cultivation method
0
‌
US Patent 7985739 Enhanced sleeping beauty transposon system and methods for using the same
0
‌
US Patent 8034334 Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
0
‌
US Patent 8088379 Modified T cell receptors and related materials and methods
0
‌
US Patent 8163293 Modified Vaccinia Virus Ankara for the vaccination of neonates
0
‌
US Patent 8211422 Chimeric receptor genes and cells transformed therewith
0
‌
US Patent 8227432 Transposon system and methods of use
0
‌
US Patent 8236560 Modified Vaccinia Ankara virus variant and cultivation method
0
‌
US Patent 8268325 Modified Vaccinia Ankara virus variant
0
‌
US Patent 8268329 Modified
0
‌
US Patent 8278036 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 8309098 Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)
0
‌
US Patent 8372622 Modified vaccinia virus ankara for the vaccination of neonates
0
‌
US Patent 8399645 Chimeric receptors with 4-1BB stimulatory signaling domain
0
‌
US Patent 8404658 RNA interference for the treatment of heart failure
0
‌
US Patent 8454972 Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen
0
‌
US Patent 8470598 Modified Vaccinia Ankara virus variant and cultivation method
0
‌
US Patent 8557779 Cancer vaccine composition
0
‌
US Patent 8648104 Method for treating proliferative disorders associated with mutations in c-Met
0
‌
US Patent 8697854 High affinity T cell receptor and use thereof
0
‌
US Patent 8796414 Identification and use of novopeptides for the treatment of cancer
0
‌
US Patent 8906682 Methods for treatment of cancer
0
‌
US Patent 8911993 Compositions for treatment of cancer
0
‌
US Patent 8916381 Methods for treatment of cancer
0
‌
US Patent 8975071 Compositions for treatment of cancer
0
‌
US Patent 9101584 Methods for treatment of cancer
0
‌
US Patent 9102760 Compositions for treatment of cancer
0
‌
US Patent 9102761 Compositions for treatment of cancer
0
‌
US Patent 9115402 Compositions and methods of identifying tumor specific neoantigens
0
‌
US Patent 9556237 Antiviral rift valley fever virus peptides and methods of use
0
‌
US Patent 9909159 Highly selective nucleic acid amplification primers
0
‌
US Patent 9962453 Immunogenic compound
0
‌
US Patent 10202640 Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
0
‌
US Patent 10426824 Compositions and methods of identifying tumor specific neoantigens
0
‌
US Patent 10801070 Compositions and methods for diagnosing, evaluating and treating cancer
0
‌
US Patent 10835585 Shared neoantigens
0
‌
US Patent 10975442 Molecular biomarkers for cancer immunotherapy
0
‌
US Patent 10993997 Methods for profiling the t cell repertoire
0
‌
US Patent 11421016 Cancer neoepitopes
0
‌
US Patent 11549149 Compositions and methods for detecting a mutant variant of a polynucleotide
0
‌
US Patent 6867041 Simultaneous stimulation and concentration of cells
0
‌
US Patent 6869794 Complementing cell lines
0
‌
US Patent 6887466 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
0
‌
US Patent 6905680 Methods of treating HIV infected subjects
0
‌
US Patent 6905681 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 6905874 Simultaneous stimulation and concentration of cells
0
‌
US Patent 6913752 Modified Vaccinia Ankara virus variant
0
‌
US Patent 6913922 Serotype of adenovirus and uses thereof
0
‌
US Patent 6923973 Peptide and DNA immunization against Coccidioides immitis infections
0
‌
US Patent 6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors
0
‌
US Patent 6936466 Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors
0
‌
US Patent 6943019 Methods and vector constructs useful for production of recombinant AAV
0
‌
US Patent 6953690 Compositions and methods for helper-free production of recombinant adeno-associated viruses
0
‌
US Patent 6955808 Capsid-modified recombinant adenovirus and methods of use
0
‌
US Patent 6974695 Complementing cell lines
0
‌
US Patent 6991797 M. tuberculosis antigens
0
‌
US Patent 7029848 High throughput screening of gene function using libraries for functional genomics applications
0
‌
US Patent 7045313 Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
0
Patent Primary Examiner
‌
Sean E Aeder
0
CPC Code
‌
C12Q 1/6886
0

Find more entities like US Patent 11939637 Molecular biomarkers for cancer immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo